• Health & Medicine
• Policy & Insight

Opinion: ‘The idea that a tobacco company might profit off my disease appals me’

Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura. Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura.

1 September 2021

• Health & Medicine
• Policy & Insight

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage. During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

27 August 2021

• Health & Medicine

Smoking among young adults increased by 25% during first lockdown

Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown. Researchers also found the number of high-risk drinkers rose by 40%, with over 4.5 million adults classed as 'high-risk drinkers' during the first lockdown.

25 August 2021

• Health & Medicine
• Science & Technology

Cancer Research UK reports record levels of investment in its spinouts

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year. The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

24 August 2021

• For Researchers

The (un)usual suspects – how early detection research embraces interdisciplinary science

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

20 August 2021

• Health & Medicine
• Policy & Insight

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role. Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

19 August 2021

• Science & Technology
• Health & Medicine

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021

• For Researchers

On your marks, get set… start-up!

Explore three of the latest companies to come out of one of our entrepreneurial programmes. Explore three of the latest companies to come out of one of our entrepreneurial programmes.

13 August 2021

• Health & Medicine

New drug combo for advanced breast cancer approved for NHS in England

People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England. People with a certain type of advanced breast cancer will now have routine access to a new treatment option in England.

13 August 2021

• Health & Medicine

New option to treat advanced oesophageal cancer approved for NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

11 August 2021

• Science & Technology

Zooming in: Fine-tuning the picture to diagnose oesophageal cancer earlier 

Our researchers have developed specialised cameras to detect cancer cells that can be hard for both surgical cameras and the naked eye to spot. Our researchers have developed specialised cameras to detect cancer cells that can be hard for both surgical cameras and the naked eye to spot.

11 August 2021